KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Interest Coverage Ratio (2019 - 2024)

Inovio Pharmaceuticals' Interest Coverage Ratio history spans 6 years, with the latest figure at 177.05 for Q1 2024.

  • For Q1 2024, Interest Coverage Ratio fell 26.28% year-over-year to 177.05; the TTM value through Dec 2024 reached 632.05, down 436.93%, while the annual FY2024 figure was 632.05, 436.93% down from the prior year.
  • Interest Coverage Ratio for Q1 2024 was 177.05 at Inovio Pharmaceuticals, down from 97.03 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 9.0 in Q1 2020 and bottomed at 332.19 in Q2 2022.
  • The 5-year median for Interest Coverage Ratio is 118.16 (2023), against an average of 128.94.
  • The largest annual shift saw Interest Coverage Ratio skyrocketed 79.3% in 2020 before it crashed 1429.38% in 2021.
  • A 5-year view of Interest Coverage Ratio shows it stood at 27.47 in 2020, then crashed by 699.62% to 219.67 in 2021, then increased by 18.76% to 178.46 in 2022, then soared by 45.63% to 97.03 in 2023, then crashed by 82.47% to 177.05 in 2024.
  • Per Business Quant, the three most recent readings for INO's Interest Coverage Ratio are 177.05 (Q1 2024), 97.03 (Q4 2023), and 113.41 (Q3 2023).